The theme of the main conference which will held on the 14th and 15th of October will be Improving Access, Improving Quality. It will examine how regulators can be more efficient in approving clinical trials and product registration, and how the quality of medicines can be better assured, be they globally supplied or locally manufactured.
The post conference symposium will be themed Personalized Health Care – Preparing Africa for the Future Today. The symposium will explore the convergence of drug discovery and testing, as well as medicine use with big data and 4IR, and how Africa can position itself in the coming revolution.
Venue: Johannesburg, South Africa
Now in its 4th year, PharmaConnect Africa has become an ideal platform to network and market services and products to a wide and diverse audience from across the African continent and beyond. We would therefore like to invite you to be a key partner and sponsor the event and /or exhibit your services and products at the venue. Please refer to the annexures and website for more information regarding sponsorship and exhibition packages. Feel free to contact the secretariat with any queries for sponsorship and exhibition.
The conference and symposium will follow a roundtable format with plenary speakers and discussants for each of the thematic area, followed by Q&A sessions. We have found that this engenders important dialogue.
Research presentations relevant to the main conference and the symposium are hereby invited. Abstracts for scientific poster and oral presentations (12 min) from researchers and students can be submitted to the secretariat for consideration by the Scientific Committee.
Role of Clinical Research Organizations (CRO) and Product Development Partnerships (PDP).
There has been an increase in CROs and PDPs working across the continent. How has their work been facilitated/retarded, and do they enhance local healthcare systems? Is the value that they bring recognized by national governments, and does that outweigh perceived risks?
Pharmacovigilance is increasingly becoming important. It ensures that medicines and vaccines are safe to use and that there is oversight from the regulator and manufacturers. This session will discuss what different roleplayers are doing to enhance pharmacovigilance globally and in Africa. It will touch on important lessons learnt and the gaps identified.
Medical Device Regulation – Where are we and what to expect next? – SANAS / SAHPRA.
Despite these high expenditures on medicines, access to essential medicines and products is still highly restricted. Low local manufacturing capacity leads to reliance on imported medicines. This often leads to non-availability of the commodity. In the public sector, across Africa, the availability of essential medicines has been reported to be less than 60% by the World Health Organisation (WHO).
The collaboration of local producers with innovator companies is essential but it is not happening at visible scale. What are the barriers to collaboration and how can they be removed? What opportunities are presented by collaboration between would-be competitors? What benefits accrue to governments and patients when there is collaboration?
Please contact us for more info on Sponsorship Packages
Stands are allocated strictly on the basis of first come, first served. Exhibition stands are 6sqm and will be located in the venue where all refreshments and lunches will be served. The floor plan will be finalized a week before the conference. Exhibitors will be contacted in order of bookings received to confirm their preferred stand and specific requirements.